GH Research Plc (GHRS)
28.10
-0.23
(-0.81%)
USD |
NASDAQ |
Aug 24, 16:00
28.09
-0.01
(-0.04%)
After-Hours: 20:00
GH Research Enterprise Value : 1.567B for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.567B |
| August 21, 2026 | 1.582B |
| August 20, 2026 | 1.606B |
| August 19, 2026 | 1.683B |
| August 18, 2026 | 1.679B |
| August 17, 2026 | 1.696B |
| August 14, 2026 | 1.662B |
| August 13, 2026 | 1.573B |
| August 12, 2026 | 1.713B |
| August 11, 2026 | 1.634B |
| August 10, 2026 | 1.665B |
| August 07, 2026 | 1.716B |
| August 06, 2026 | 1.741B |
| August 05, 2026 | 1.637B |
| August 04, 2026 | 1.637B |
| August 03, 2026 | 1.573B |
| July 31, 2026 | 1.564B |
| July 30, 2026 | 1.586B |
| July 29, 2026 | 1.558B |
| July 28, 2026 | 1.557B |
| July 27, 2026 | 1.543B |
| July 24, 2026 | 1.510B |
| July 23, 2026 | 1.534B |
| July 22, 2026 | 1.600B |
| July 21, 2026 | 1.584B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.527B |
| July 17, 2026 | 1.608B |
| July 16, 2026 | 1.637B |
| July 15, 2026 | 1.486B |
| July 14, 2026 | 1.475B |
| July 13, 2026 | 1.378B |
| July 10, 2026 | 1.457B |
| July 09, 2026 | 1.505B |
| July 08, 2026 | 1.481B |
| July 07, 2026 | 1.484B |
| July 06, 2026 | 1.434B |
| July 02, 2026 | 1.492B |
| July 01, 2026 | 1.451B |
| June 30, 2026 | 1.483B |
| June 29, 2026 | 1.501B |
| June 26, 2026 | 1.484B |
| June 25, 2026 | 1.306B |
| June 24, 2026 | 1.260B |
| June 23, 2026 | 1.198B |
| June 22, 2026 | 1.104B |
| June 18, 2026 | 1.113B |
| June 17, 2026 | 1.080B |
| June 16, 2026 | 972.92M |
| June 15, 2026 | 997.12M |
| June 12, 2026 | 1.044B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Atai Beckley, Inc. | 2.501B |
| Avadel Pharmaceuticals Plc | -- |
| Jazz Pharmaceuticals Plc | 18.70B |
| Eli Lilly & Co. | 1.220T |
| Perrigo Co. Plc | 5.038B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -15.15M |
| Total Expenses (Quarterly) | 15.15M |
| EPS Diluted (Quarterly) | -0.2276 |
| Earnings Yield | -3.51% |
| Normalized Earnings Yield | -3.841 |